C-reactive protein plays a marginal role in cognitive decline: A systematic review and meta-analysis

International Journal of Geriatric Psychiatry

Volumn 30, Issue 2, 2015, Pages 156-165

  Yang, Jin ^a   Fan, Cuifang ^a   Pan, Lei ^a   Xie, Minghua ^a   He, Qiqiang ^a   Li, Dejia ^a   Wang, Suqing ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

C reactive protein; Cognitive decline; Meta analysis

Indexed keywords

C REACTIVE PROTEIN;

AGING; COGNITION; COGNITIVE DEFECT; HUMAN; META ANALYSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; COGNITION DISORDERS; METABOLISM; PSYCHOLOGICAL RATING SCALE; RISK; RISK FACTOR;

C-REACTIVE PROTEIN; COGNITION DISORDERS; HUMANS; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 84921307233     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4236     Document Type: Review

References (44)

1. Alley DE, Crimmins EM, Karlamangla A, Hu P, Seeman TE. 2008. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci 63: 50-5.
2. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ. 2000. Microglia, amyloid and dementia in alzheimer disease. A correlative study. Neurobiol Aging 21: 39-47.
3. Cagnin A, Brooks DJ, Kennedy AM, et al. 2001. In-vivo measurement of activated microglia in dementia. The Lancet 358: 461-467.
4. Campbell IL, Abraham CR, Masliah E, et al. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90: 10061-5.
5. Cesari M, Penninx BW, Newman AB, et al. 2003. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108: 2317-22.
6. Crane PK, Narasimhalu K, Gibbons LE, et al. 2008. Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol 61: 1018-27.
7. Davies HT, Crombie IK, Tavakoli M. 1998. When can odds ratios mislead? BMJ 316: 989-91.
8. Dersimonian R, Kacker R. 2007. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28: 105-14.
9. Dik MG, Jonker C, Hack CE, et al. 2005. Serum inflammatory proteins and cognitive decline in older persons. Neurology 64: 1371-7.
10. Du Clos TW. 2000. Function of C-reactive protein. Ann Med 32: 274-8.
11. Dziedzic T. 2006. Systemic Inflammatory Markers and Risk of Dementia. Am J Alzheimers Dis Other Demen 21: 258-262.
12. Eikelenboom P, Rozemuller JM, van MuiswinkeL FL. 1998. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression. Exp Neurol 154: 89-98.
13. Engelhart MJ, Geerlings MI, Meijer J, et al. 2004. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61: 668-72.
14. Gimeno D, Marmot MG, Singh-Manoux A. 2008. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 33: 1322-34.
15. Higgins JP, Thompson SG. 2002. Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-58.
16. Hoffmeister A, Rothenbacher D, Bazner U, et al. 2001. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87: 262-6.
17. Johnston SC, Messina LM, Browner WS, et al. 2001. C-Reactive Protein Levels and Viable Chlamydia pneumoniae in Carotid Artery Atherosclerosis. Stroke 32: 2748-2752.
18. Jones RW. 2001. Inflammation and Alzheimer's disease. Lancet 358: 436-7.
19. Jordanova V, Stewart R, Davies E, Sherwood R, Prince M. 2007. Markers of inflammation and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry 22: 966-73.
20. Koenig W, Sund M, Frohlich M, et al. 1999. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99: 237-42.
21. Koyama A, Okereke OI, Yang T, et al. 2012. Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol 69: 824-31.
22. Krabbe KS, Mortensen EL, Avlund K, et al. 2009. Genetic priming of a proinflammatory profile predicts low IQ in octogenarians. Neurobiol Aging 30: 769-81.
23. Laurin D, David Curb J, Masaki KH, White LR, Launer LJ. 2009. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol Aging 30: 1724-7.
24. Luciano M, Marioni RE, Gow AJ, Starr JM, Deary IJ. 2009. Reverse causation in the association between C-reactive protein and fibrinogen levels and cognitive abilities in an aging sample. Psychosom Med 71: 404-9.
25. Mangiafico RA, Sarnataro F, Mangiafico M, Fiore CE. 2006. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing 35: 60-5.
26. Marioni RE, Stewart MC, Murray GD, et al. 2009. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom Med 71: 901-6.
27. Mooijaart SP, Sattar N, Trompet S, et al. 2011. C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study. PLoS One 6: e23890.
28. Petersen RC, Smith GE, Waring SC, et al. 1999. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-8.
29. Perneczky R, Wagenpfeil S, Komossa K, et al. 2006. Mapping scores onto stages: Mini-mental state examination and clinical dementia rating. Am J Geriatri Psychiatry. 14: 139-44.
30. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FG. 2007. Cardiovascular diseases and decline in cognitive function in an elderly community population: the EdinburghArtery Study. Psychosom Med 69: 425-34.
31. Ravaglia G, Forti P, Maioli F, et al. 2005. Serum C-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci 60: 1017-21.
32. Ridker PM, Stampfer MJ, Rifai N. 2001. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285: 2481-5.
33. Schmidt R, Schmidt H, Curb JD, et al. 2002. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52: 168-74.
34. Schram MT, Euser SM, de Craen AJ, et al. 2007. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 55: 708-16.
35. Stang A. 2010. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-5.
36. Stroup DF, Berlin JA, Morton SC, et al. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-12.
37. Teunissen CE, L Tjohann D, von Bergmann K, et al. 2003a. Combination of serum markers related to several mechanisms in Alzheimer's disease. Neurobiol Aging 24: 893-902.
38. Teunissen CE, van Boxtel MP, Bosma H, et al. 2003b. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134: 142-50.
39. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, et al. 2004. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol A Biol Sci Med Sci 59: 268-74.
40. Weaver JD, Huang MH, Albert M, et al. 2002. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59: 371-8.
41. Wright CB, Sacco RL, Rundek T, et al. 2006. Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 15: 34-8.
42. Yaffe K, Lindquist K, Penninx BW, et al. 2003. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61: 76-80.
43. Yasojima K, Schwab C, Mcgeer EG, Mcgeer PL. 2000. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 887: 80-9.
44. Zhang J, Yu KF. 1998. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 280: 1690-1.